Professor Paul Kalra
- Honorary Clinical Senior Lecturer (School of Health & Wellbeing)
Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Southwick Hill Rd, Cosham, PO6 3LY
Publications
2022
Kalra, P. R. et al. (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet, 400(10369), pp. 2199-2209. (doi: 10.1016/S0140-6736(22)02083-9) (PMID:36347265)
Kalra, P. R. et al. (2022) Rationale and design of a randomised trial of intravenous iron in patients with heart failure. Heart, 108(24), pp. 1979-1985. (doi: 10.1136/heartjnl-2022-321304) (PMID:35948408) (PMCID:PMC9726969)
Austin, R. C., Schoonhoven, L., Richardson, A., Kalra, P. R. and May, C. R. (2022) Qualitative interviews results from heart failure survey respondents on the interaction between symptoms and burden of self-care work. Journal of Clinical Nursing, (doi: 10.1111/jocn.16484) (PMID:35945903) (Early Online Publication)
Austin, R. C., Schoonhoven, L., Koutra, V., Richardson, A., Kalra, P. R. and May, C. R. (2022) SYMptoms in chronic heart failure imPACT on burden of treatment (SYMPACT): a cross‐sectional survey. ESC Heart Failure, 9(4), pp. 2279-2290. (doi: 10.1002/ehf2.13904) (PMID:35451208) (PMCID:PMC9288776)
2021
Graham, F. J., Pellicori, P. , Ford, I. , Petrie, M. C. , Kalra, P. R. and Cleland, J. G.F. (2021) Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials. Clinical Research in Cardiology, 110(8), pp. 1299-1307. (doi: 10.1007/s00392-021-01837-8) (PMID:33755777)
Austin, R. C., Schoonhoven, L., Clancy, M., Richardson, A., Kalra, P. R. and May, C. R. (2021) Do chronic heart failure symptoms interact with burden of treatment? Qualitative literature systematic review. BMJ Open, 11(7), e047060. (doi: 10.1136/bmjopen-2020-047060) (PMID:34330858) (PMCID:PMC8327846)
2020
Austin, R. C., Schoonhoven, L., Richardson, A., Kalra, P. R. and May, C. R. (2020) How do SYMPtoms and management tasks in chronic heart failure imPACT a person's life (SYMPACT)? Protocol for a mixed-methods study. ESC Heart Failure, 7(6), pp. 4472-4477. (doi: 10.1002/ehf2.13010) (PMID:32940966) (PMCID:PMC7754908)
Sorbets, E. et al. (2020) Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. European Heart Journal, 41(3), pp. 347-356. (doi: 10.1093/eurheartj/ehz660) (PMID:31504434) (PMCID:PMC6964227)
2019
Vidal-Petiot, E. et al. (2019) Chronic kidney disease has a graded association with death and cardiovascular outcomes in stable coronary artery disease: an analysis of 21,911 patients from the CLARIFY registry. Journal of Clinical Medicine, 9(1), 4. (doi: 10.3390/jcm9010004)
Clark, A. L., Kalra, P. R., Petrie, M. C. , Mark, P. B. , Tomlinson, L. A. and Tomson, C. R.V. (2019) Change in renal function associated with drug treatment in heart failure: national guidance. Heart, 105(12), pp. 904-910. (doi: 10.1136/heartjnl-2018-314158) (PMID:31118203) (PMCID:PMC6582720)
2018
Kalra, P. R., Greenlaw, N., Ford, I. , Steg, P. G. and Fox, K. M. (2018) The reply. American Journal of Medicine, 131(3), e129. (doi: 10.1016/j.amjmed.2017.09.019) (PMID:29454433)
Articles
Kalra, P. R. et al. (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet, 400(10369), pp. 2199-2209. (doi: 10.1016/S0140-6736(22)02083-9) (PMID:36347265)
Kalra, P. R. et al. (2022) Rationale and design of a randomised trial of intravenous iron in patients with heart failure. Heart, 108(24), pp. 1979-1985. (doi: 10.1136/heartjnl-2022-321304) (PMID:35948408) (PMCID:PMC9726969)
Austin, R. C., Schoonhoven, L., Richardson, A., Kalra, P. R. and May, C. R. (2022) Qualitative interviews results from heart failure survey respondents on the interaction between symptoms and burden of self-care work. Journal of Clinical Nursing, (doi: 10.1111/jocn.16484) (PMID:35945903) (Early Online Publication)
Austin, R. C., Schoonhoven, L., Koutra, V., Richardson, A., Kalra, P. R. and May, C. R. (2022) SYMptoms in chronic heart failure imPACT on burden of treatment (SYMPACT): a cross‐sectional survey. ESC Heart Failure, 9(4), pp. 2279-2290. (doi: 10.1002/ehf2.13904) (PMID:35451208) (PMCID:PMC9288776)
Graham, F. J., Pellicori, P. , Ford, I. , Petrie, M. C. , Kalra, P. R. and Cleland, J. G.F. (2021) Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials. Clinical Research in Cardiology, 110(8), pp. 1299-1307. (doi: 10.1007/s00392-021-01837-8) (PMID:33755777)
Austin, R. C., Schoonhoven, L., Clancy, M., Richardson, A., Kalra, P. R. and May, C. R. (2021) Do chronic heart failure symptoms interact with burden of treatment? Qualitative literature systematic review. BMJ Open, 11(7), e047060. (doi: 10.1136/bmjopen-2020-047060) (PMID:34330858) (PMCID:PMC8327846)
Austin, R. C., Schoonhoven, L., Richardson, A., Kalra, P. R. and May, C. R. (2020) How do SYMPtoms and management tasks in chronic heart failure imPACT a person's life (SYMPACT)? Protocol for a mixed-methods study. ESC Heart Failure, 7(6), pp. 4472-4477. (doi: 10.1002/ehf2.13010) (PMID:32940966) (PMCID:PMC7754908)
Sorbets, E. et al. (2020) Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. European Heart Journal, 41(3), pp. 347-356. (doi: 10.1093/eurheartj/ehz660) (PMID:31504434) (PMCID:PMC6964227)
Vidal-Petiot, E. et al. (2019) Chronic kidney disease has a graded association with death and cardiovascular outcomes in stable coronary artery disease: an analysis of 21,911 patients from the CLARIFY registry. Journal of Clinical Medicine, 9(1), 4. (doi: 10.3390/jcm9010004)
Clark, A. L., Kalra, P. R., Petrie, M. C. , Mark, P. B. , Tomlinson, L. A. and Tomson, C. R.V. (2019) Change in renal function associated with drug treatment in heart failure: national guidance. Heart, 105(12), pp. 904-910. (doi: 10.1136/heartjnl-2018-314158) (PMID:31118203) (PMCID:PMC6582720)
Kalra, P. R., Greenlaw, N., Ford, I. , Steg, P. G. and Fox, K. M. (2018) The reply. American Journal of Medicine, 131(3), e129. (doi: 10.1016/j.amjmed.2017.09.019) (PMID:29454433)